Codexis Profit Margin 2009-2021 | CDXS
Current and historical gross margin, operating margin and net profit margin for Codexis (CDXS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Codexis net profit margin as of June 30, 2021 is -28.16%.
|Codexis Annual Profit Margins
|Codexis Quarterly Profit Margins
||Medical - Biomedical and Genetics
Codexis is a leading protein engineering company that applies its proprietary CodeEvolver technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis? proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes.